Trial Profile
A randomized, double-blind, placebo-controlled, multicenter study to examine the effect of betahistine on body weight in obese subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Betahistine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors OBEcure
- 01 Oct 2008 Results published in the International Journal of Obesity.
- 01 Oct 2008 Primary endpoint 'Bodyweight' has not been met according to results published in the International Journal of Obesity.
- 26 Jun 2007 Status changed from in progress to completed.